Gerresheimer establishes Medical Innovation Group
Will offer new product development services
The MIG will offer product management, design and development, as well as computer-aided design (CAD), intellectual property (IP) and documentation services.
The group will initially comprise seven engineers, designers and patent management experts with a variety of skills and a disparate approach to product development. They combine knowledge of user requirements with functional, technical and production-related specifications, design, market intelligence and design and engineering expertise.
‘We are creating the basic conditions that enable us to assist customers with their project when it is still an idea and not when the product is already developed,’ said Manfred Baumann, cto/coo of Gerresheimer Regensburg. ‘Our approach to product development starts with understanding the end user.’
He added that another major benefit for customers is that design for manufacturing can be integrated into product design and development, which translates into shorter development times, because post-development optimisation of the product for polymer processing is no longer necessary.
The MIG will operate independently of Gerresheimer’s Technical Competence Centre and production facilities.
You may also like
Sustainability
Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold
Read moreGerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
Trending Articles
Relevant companies
You may also like
Sustainability
Gerresheimer improves Rating Result and is once again awarded EcoVadis Gold
Gerresheimer, among the top 4% of all rated companies, whose rating reaches a new high with 78 out of 100 points, ranking among the top 1% of the industry underlines consistent implementation of the sustainability strategy
Manufacturing
Gerresheimer to divest Moulded Glass business following strategic review
As part of its transformation into a pure-play pharma and biotech systems provider, Gerresheimer has announced plans to sell its newly formed global Moulded Glass Powerhouse. The decision follows a strategic review that identified stronger growth opportunities for the business outside the Group